PT  - JOURNAL ARTICLE
AU  - HANI EL-GABALAWY
AU  - LYN C. GUENTHER
AU  - CHARLES N. BERNSTEIN
TI  - Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities
AID  - 10.3899/jrheum.091461
DP  - 2010 May 01
TA  - The Journal of Rheumatology
PG  - 2--10
VI  - 85
4099  - http://www.jrheum.org/content/85/2.short
4100  - http://www.jrheum.org/content/85/2.full
SO  - J Rheumatol2010 May 01; 85
AB  - Immune-mediated inflammatory diseases (IMID) present a group of common and highly disabling chronic conditions that share inflammatory pathways. Several incidence and prevalence studies of IMID during the past decades have reported a considerable variation of the disease occurrence among different populations. Overall, the estimated prevalence of IMID in Western society is 5%–7%. This article provides an overview of studies of the incidence, prevalence, natural history, and comorbidities of IMID.